Scientific Publications
Cannabinoid1 (CB‐1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose
Published in 2020 by the Journal of Neural Transmission.
Fighting fire with fire: development of intranasal nalmefene to treat synthetic opioid overdose
Published in April 2019 by ASPET Journals.
Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects
Published in March 2019 by American College of Neuropsychopharmacology.
Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose
Published in 2019 by the Journal of Clinical Pharmacology.
On the Front Lines of the Opioid Epidemic: Rescue by Naloxone
Published in 2018 by the European Journal of Pharmacology.
Medication Development in opioid Addiction: Meaningful Clinical End Points
Published in 2018 by the Science Translational Medicine.
The Opioid Epidemic: Crisis and Solutions
Published in January 2018 by Annual Review of Pharmacology and Toxicology.
Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625
Published in 2010 by the Journal of Psychopharmacology.
A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse
Published in 2017 in the Journal of Medicinal Chemistry.
Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose
Published in 2016 by the American College of Clinical Pharmacology.